HARVEY SHIELDS COLLINS, M.D.; TOM FITE PAINE JR., M.D.; EDWARD BUIST WELLS, M.D.; MAXWELL FINLAND, M.D., F.A.C.P.
There has been a notable lack of success in the treatment of typhoid fever and salmonella infections with the chemotherapeutic and antibiotic agents that are now available. This has been true even with streptomycin which is usually quite effective against the causative organisms in vitro. Moreover, the failures of streptomycin in these infections and in some others like brucellosis have not usually been associated with the appearance of highly resistant variants as they are in most other infections, nor have they generally been associated with the presence of large and inaccessible areas of suppuration. Because these infections may be quite
HARVEY SHIELDS COLLINS, TOM FITE PAINE, EDWARD BUIST WELLS, MAXWELL FINLAND. AUREOMYCIN—A NEW ANTIBIOTIC: EVALUATION OF ITS EFFECTS IN TYPHOID FEVER, SEVERE SALMONELLA INFECTIONS AND IN A CASE OF COLON BACILLUS BACTEREMIA(AUREOMYCIN—A NEW ANTIBIOTIC: EVALUATION OF ITS EFFECTS IN TYPHOID FEVER, SEVERE SALMONELLA INFECTIONS AND IN A CASE OF COLON BACILLUS BACTEREMIA*). Ann Intern Med. 1948;29:1077–1092. doi: 10.7326/0003-4819-29-6-1077
Download citation file:
Published: Ann Intern Med. 1948;29(6):1077-1092.
Infectious Disease, Multi-Organ Failure and Sepsis, Pulmonary/Critical Care.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use